ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "population studies"

  • Abstract Number: 0137 • ACR Convergence 2024

    The Problem of Pain in Rheumatology: Sociodemographic and Disease-related Correlates of Agreement Between Structured Data Elements and Clinical Notes in Chronic Pain Documentation Practices in EHR

    Tahmina Begum1, Bhagyavalli Veeranki1, Ogenna Chike1 and Titilola Falasinnu2, 1Stanford School of Medicine, Stanford, 2Stanford School of Medicine, Palo Alto, CA

    Background/Purpose: To create greater precision in case definitions for chronic pain in EHRs, we recently identified 15 different case definitions for chronic pain using structured…
  • Abstract Number: 2022 • ACR Convergence 2024

    Could Initiation of Sodium Glucose Co-Transporter-2 Inhibitors Reduce the Need for Conventional Urate-Lowering Therapy and Flare Medications in Patients with Gout?Population-Based Target Trial Emulation Studies

    Natalie McCormick1, Chio Yokose2, Leo Lu3, Sharan Rai1, Gregory Challener1 and Hyon K. Choi4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

    Background/Purpose: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) lower serum urate levels and are associated with reduced risk of incident gout as well as recurrent flares [Annals IM…
  • Abstract Number: 0144 • ACR Convergence 2024

    More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups

    John Chen1, Tanya Selvam1, Jeanne Darbinian2, Christopher Macko1, Nirmala Ramalingam2, Joan Lo2 and Lucy Liu2, 1Kaiser Permanente Oakland Medical Center, Oakland, CA, 2Kaiser Permanente, Oakland, CA

    Background/Purpose: Rheumatoid arthritis (RA) is a disabling, autoimmune condition affecting up to as many as 17.6 million individuals worldwide. Epidemiologic evidence in the United States…
  • Abstract Number: 2054 • ACR Convergence 2024

    Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients

    Paula García Escudero1, Marta López I Gómez2, Berta Magallanes López3, Diego Dios Santos4, Francisco Javier Toyos Sáenz de Miera5, Alicia García Dorta6, José Ángel Hernández Beriain7, Íñigo Rúa-Figueroa8, cristiana sieiro santos9, Elvira Díez Álvarez10, Marta Ibáñez Martínez11, Beatriz Frade-Sosa12, Judit Font Urgelles13, Meritxell Sallés Lizarzaburu14, Elena Riera Alonso15, Ernesto Trallero Araguás16, Eugenia Enríquez Merayo17, Maria Rodriguez-Laguna18, irene monjo19, Carolina Merino20, Paloma Vela-Casasempere21, Ignacio Vázquez Gómez22, Jose Alberto Miranda Filloy23, Rafael Benito Melero-Gonzalez24, Clara Garcia Belando25, Giuliano Boselli26, Alina Lucica Boteanu27, Dolly Viviana Fiallo Suárez28, Cristina Corrales Selaya29, ALBERTO MARIANO RUIZ ROMAN30 and Jaime Calvo-Alén31, 1Hospital Universitario Araba, Vitoria, 2Hospital Universitario Alava, Vitoria, Pais Vasco, Spain, 3Hospital de la Santa Creu i Sant Pau, Barcelona, 4C. H. U. A Coruña, C. H. U. A Coruña, 5H. U. Virgen Macarena, H. U. Virgen Macarena, 6Rheumatologist, La Laguna, Spain, 7Rheumatology Department. Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran C, Spain, 8Department of Rheumatology, Hospital Universitario Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas GC, Spain, 9Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 10Complejo Asistencial Universitario de León, León, Spain, 11Hospital Clínico Universitario de Salamanca, Salamanca, Spain, 12Hospital Clinic de Barcelona, Barcelona, Spain, 13Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 14Althaia Xarxa Assistencial Universitària Manresa, Manresa, Catalonia, Spain, 15Mutua de Terrasa, Barcelona, 16Hospital Vall D'Hebron, Barcelona, Spain, 17Hospital 12 de Octubre, Madrid, 18Resident in Rheumatology, Madrid, Spain, 19University Hospital La Paz, Madrid, Spain, 20Hospital Universitario Puerta de Hierro Majadahonda., Majadahonda (Madrid), Spain, 21Hospital General Universitario Alicante, Alicante, Spain, 22H. U. Dr. Peset, Valencia, 23C. H. U. Lucus Augusti, Lugo, Spain, 24CHU Ourense, O Carballino, Spain, 25H. C. U. Virgen de la Arrixaca, Murcia, 26hospital miguel servet, zaragoza, Aragon, Spain, 27H.U. Ramón y Cajal, Madrid, Spain, 28H. U. de Gran Canaria. Dr. Negrin, H. U. de Gran Canaria, 29Rheumatology, Marques de Valdecilla University Hospital. IDIVAL, Santander, Cantabria, Spain, 30Hospital Universitario Juan Ramón Jiménez, Huelva, Spain, 31Department of Rheumatology, Hospital Araba, Vitoria, Pais Vasco, Spain

    Background/Purpose: VEXAS syndrome is an autoinflammatory disorder caused by a mutation in the UBA1 gene, which leads to a heterogeneous clinical presentation and progressive bone…
  • Abstract Number: 0148 • ACR Convergence 2024

    The Incidence and Prevalence of Sarcoidosis in England

    Katie Bechman1, Kathryn Biddle1, Mark Russell2, Mark Gibson1, maryam adas1, Zijing Yang2, Edward Alveyn1, deepak Nagra2, Sam Norton2, Surinder biring1 and James Galloway3, 1King's College London, London, United Kingdom, 2King's College London, London, England, United Kingdom, 3Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Sarcoidosis is heterogeneous condition, ranging from mild self-limiting disease to severe organ involvement and death. Despite its clinical significance, the epidemiological landscape in England…
  • Abstract Number: 2126 • ACR Convergence 2024

    Analysis of the Evolution of Bone Mineral Density in the Spanish Population: Results of the OsteoSER Study

    Carmen Gomez Vaquero1, Marta Domínguez-Álvaro2, Daniel Seoane-Mato3, Pilar Peris4, Santos Castañeda5, Eduardo Kanterewicz Binstock6, Ramon Mazzucchelli7, Luis Arboleya8, Miguel Bernad9, Antonio Alvarez-Cienfuegos10, Blanca Correa11, Luis-Maria Jimenez-Liñan12, Carmen Mateo-Pascual13, Mª Mercedes Molina del Rio14, Mercedes Retamal-Ortiz15, Aida Fatima Lopez-Laguna16, Ruth Molera-Valero17, Sara Alvar-Pariente18, Antonio Pascual19, Adolfo Arias-Senso20, Nuria Perez-Gutierrez21, Soledad Garcia-Frias22, David Bouza-Alvarez23, Susana Sostres24, Daniel Suarez-Hernandez25, Ana Zamora-Casal26, Cristina Garcia-Ramirez27 and Enrique González-Dávila28, and OsteoSER Project Collaborative Group, 1Hospital Universitari de Bellvitge, 08907 L'Hospitalet, Catalonia, Spain, 2Sociedad Española de Reumatología, Madrid, Spain, 3Sociedad Española de Reumatología, Madrid, Madrid, Spain, 4Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain, 5Hospital Universitario de la Princesa, Madrid, Spain, 6Hospital Universitari de Vic (Consorci Hospitalari de Vic), Barcelona, Spain, 7Hospital Universitario Fundacion Alcorcon, Madrid, Spain, 8Hospital Universitario Central de Asturias, Oviedo, Spain, 9Hospital Universitario La Paz, Madrid, Spain, 10Conselleria de Sanitat/Hospital de la Vega Baja, Orihuela, Comunidad Valenciana, Spain, 11Clínica Sanz y Correa, A Coruña, Spain, 12Hospital Don Benito-Villanueva, Don Benito, Spain, 13Centro de Salud Fuencarral, distrito Fuencarral-El Pardo, Madrid, Spain, 14Centro de Atención Primaria Viladecans Montbaig, Sant Climent de Llobregat, Spain, 15Centro de Salud Don Benito Oeste, Don Benito, Spain, 16Centro de Salud El Molar, El Molar, Spain, 17Centro de Salud Orihuela 1-El Rabaloche, Orihuela, Spain, 18Centro de Salud Malpica, Malpica, Spain, 19Centro de salud Ronda-Norte y Ronda-Sur Santa Bárbara, Ronda, Spain, 20Centro de Salud de Santa Amalia, Santa Amalia, Spain, 21Centro de Atención Primaria Ramona Via i Pros, El Prat de Llobregat, Spain, 22Centro de Salud de Cortes de la Frontera, Cortes de la Frontera, Spain, 23Centro de Salud Elviña Mesoiro, A Coruña, Spain, 24Centro de Atención Primaria Cap 17 de setembre, El Prat de Llobregat, Spain, 25Centro de Salud de Benejuzar, Benezujar, Spain, 26Centro de Salud Os Mallos, A Coruña, Spain, 27Centro de Salud Ronda-Sur Santa Bárbara, Ronda, Spain, 28Departamento de Matemáticas, Estadística e Investigación Operativa, Universidad La Laguna, San Cristobal de La Laguna, Spain

    Background/Purpose: The bone mineral density (BMD) reference data for the Spanish population comes from the study Multicentre Research Project on Osteoporosis (MPRO), concluded in 1989.Our…
  • Abstract Number: 0159 • ACR Convergence 2024

    Prevalence and Potential Factors Associated with Polypharmacy in Individuals with Systemic Lupus Erythematosus

    Jianing Yang1, Jinoos Yazdany2, S. Sam Lim3, Brad Pearce3 and Laura Plantinga4, 1Highland Hospital, AHS, San Leandro, CA, 2UCSF, San Francisco, CA, 3Emory University, Atlanta, GA, 4University of California, San Francisco, San Francisco, CA

    Background/Purpose: Polypharmacy is associated with an increased risk of adverse drug effects and medication nonadherence. However, the prevalence of polypharmacy and the medications and factors…
  • Abstract Number: 2415 • ACR Convergence 2024

    Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network

    Nehad Soloman1, Jawad Bilal2, Romy Cabacungan3, Scott Milligan4, Andrew Sharobeem5, John Tesser6 and Henry Leher7, 1Arizona Arthritis & Rheumatology Associates, P.C., Glendale, AZ, 2University of Arizona, Tucson, AZ, 3Arizona Arthritis & Rheumatology Associates, P.C., Tucson, AZ, 4Trio Health, Louisville, CO, 5AARA, Peoria, AZ, 6Arizona Arthritis & Rheumatology Associates, Phoenix, AZ, 7Aurinia Pharma, Stowe, VT

    Background/Purpose: Lupus nephritis (LN) has been estimated to develop in up to 40% of all patients with systemic lupus erythematosus (SLE), with higher rates in…
  • Abstract Number: 0161 • ACR Convergence 2024

    Cross Country Burden of Osteoarthritis in Latin America and Caribbean from 1990-2021: A Comparative and Consistent Benchmarking Analysis for the Global Burden of Disease Study 2022

    malay rathod1, Eva Kalra2, Rafael Sanchez-Dopazo,3, Janmay Vala4, Saif Syed5, Akhilesh Sharma6, Ashwinikumar Shandilya7, Asmita Gera8, Mohit Lakkimsetti9, Juhi Patel10, VISHRANT AMIN11 and Hardik Desai12, 1Monmouth Medical Center, Rutgers University, Ewing, NJ, 2Trident Medical Cente, Charleston, SC, 3Larkin Community Hospital Palm Springs Campus, Hialeah, FL, 4Terna Medical College, Navi Mumbai, Maharashtra, India, 5Royal college of Surgeons,Dublin,Ireland, Dublin, Dublin, Ireland, 6Adesh Institute of Medical Sciences and Research, Bhatinda, India, 7Rural Medical college. Pravara institute of medical sciences., Ahmednagar, India, 8Tianjin medical University, Tianjin, China, Tianjin, Tianjin, China (People's Republic), 9Mamata Medical College,Khammam, Khammam, Telangana, India, 10GMERS MEDICAL COLLEGE VALSAD, 382330, Gujarat, India, 11GMERS MEDICAL COLLEGE VALSAD, Ahmedabad, India, 12Gujarat Adani Institute of Medical Sciences, Bhuj, India

    Background/Purpose: Osteoarthritis (OA) poses a significant and escalating health challenge across Latin America and the Caribbean (LAC), driven by demographic shifts, lifestyle factors, and varying…
  • Abstract Number: 2520 • ACR Convergence 2024

    Prevalence and Incidence of Giant Cell Arteritis Among Medicare Fee-For-Service Beneficiaries: United States, 2014–2019

    Peter Merkel1, Yi Peng2, Patrick Zueger2, Clara Ziadeh3, Ana B. Romero4, Richard Thielen3 and Denise Kruzikas3, 1Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 2AbbVie Inc, North Chicago, IL, 3AbbVie Inc., North Chicago, IL, 4AbbVie, North Chicago, IL

    Background/Purpose: Giant cell arteritis (GCA) is a vasculitis affecting individuals aged ≥50 years. Over 80% of patients with GCA are aged ≥70 years, reflecting a…
  • Abstract Number: 0365 • ACR Convergence 2024

    Patients’ Behaviors and Beliefs Around Dietary Changes Among a Cohort of Patients with Rheumatic Disease

    Aaron Stubbs, Deeba Minhas, Anne Arewasikporn and Andrew Schrepf, University of Michigan, Ann Arbor, MI

    Background/Purpose: Dietary interventions may help manage inflammation and are considered for adjunctive treatment of rheumatic diseases.  Our study aimed to explore patients' behaviors and beliefs…
  • Abstract Number: 2673 • ACR Convergence 2024

    Changes in Mortality Risk After Stopping Glucocorticosteroids – a Population-based Study in Rheumatoid Arthritis

    Diane Lacaille1, Coraline Danieli2, Kasra Moolooghy1 and Michal Abrahamowicz3, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2Research Institute of McGill University Health Center (RI-MUHC), Montreal, QC, Canada, 3McGill University, Verdun, Canada

    Background/Purpose: Glucocorticosteroid (GC) use is associated with increased mortality risk, especially from cardiovascular diseases (CVD) and infections, with dose and duration of use influencing risk.…
  • Abstract Number: 0735 • ACR Convergence 2024

    ANCA-associated Vasculitis (AAV) and Long-term Risk of Cardiovascular Disease: Large-scale Propensity-matched Global Retrospective Cohort Study

    Sebastian Klapa1, Henry Nording2, Marlene Ludwig3, Sabrina Arnold4, Khalaf Kridin5, Anja Staehle6, Ralf Ludwig7 and Peter Lamprecht4, 1University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, 2University of Lübeck, Cardioimmunology Research Group, Lübeck, Germany, 3Independent Researcher, Groß Grönau, Germany, 4University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, Germany, 55. Bar-Ilan University, Azrieli Faculty of Medicine, Safed, Israel, 6University of Lübeck, Department of Rheumatology and Immunology, Lübeck, Germany, 7University of Lübeck, Lübeck Institute of Experimental Dermatology, Lübeck, Germany

    Background/Purpose: In spite of significantly improved therapy during the last years, long-term morbidity and mortality has remained high in ANCA-associated vasculitis (AAV). The main causes…
  • Abstract Number: 0997 • ACR Convergence 2024

    Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus

    Zoe Reed1, Janis Campbell2, Xana Howard1, Teresa Aberle1, Bridget Parrish1, Wade DeJager3, Cristina Arriens1, Joan Merrill4 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, 4Oklahoma Medical Research Foundation, Oklahoma City 73104, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) has a complex etiology with genetic predispositions interacting with environmental factors. Extensive environmental exposure information is now publicly available based…
  • Abstract Number: 1223 • ACR Convergence 2024

    Community Based Study of Prevalence and Social Factors for Chronic Pain and Fibromyalgia in Women from Western India

    Vidit Gupta1, Diksha Mishra1, Shikhar Singh1, Vaishnavi Chowhan1, Shraddha Thorat1, Kavita Krishna2 and Sandeep Kansurkar3, 1Bharati Vidyapeeth (Deemed to be University) Medical College, Pune), Pune, Maharashtra, India, 2Bharati Vidyapeeth University Medical College and Hospital, Pune, Maharashtra, India, 3Bharati Vidyapeeth University Medical College, Pune, India

    Background/Purpose: Fibromyalgia is a disorder of chronic widespread pain. There is huge burden of this entity in community but there is scarcity of quality studies…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology